Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Finnadvance logo — Finnadvance creates small chips for drug discovery, mimickin...

Finnadvance

Finnadvance creates small chips for drug discovery, mimicking organs and reducing animal testing, for rare diseases and personalized medicine.

Founded 2018 Finland Finland 11-50 employees Seed Total: $1.75M Biotechnology, Life Sciences

General Information

Company Name Finnadvance
Founded Year 2018
Location Finland Finland
Employees 11-50
Industries Biotechnology, Life Sciences
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Finnadvance. To contact Finnadvance, visit finnadvance.fi.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Finnadvance compare?

A PDF of Finnadvance and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Finnadvance soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Finnadvance

Finnadvance, a Finnish biotechnology startup founded in 2018, has gained attention in the pharmaceutical and research sectors for its innovative approach to drug discovery. The company's slogan, "Finnadvance creates small chips for drug discovery, mimicking organs and reducing animal testing, for rare diseases and personalized medicine." succinctly captures its mission. Finnadvance's development of small chips that simulate human organ functions has the potential to revolutionize the drug discovery process by increasing accuracy and efficiency while reducing costs associated with animal experimentation. This technology is particularly significant for the development of therapies for rare diseases and personalized medicine. The company recently secured a noteworthy €1.20M Seed Round investment on 08 April 2022, with participation from prominent investors such as Icebreaker.vc, Takoa Invest, Athensmed, Voima Ventures, Sauli Törmälä, and Leena Niemistö. Operating from Finland, Finnadvance is positioned to make a meaningful impact within the biotechnology and life sciences industries.

Business keywords: Drug discovery, Organ mimicking chips, Rare diseases, Personalized medicine, Pharmaceutical industry, Research, Human organ emulation, Cost reduction, Animal testing, Therapies, Uncommon illnesses, Efficiency enhancement, Medical technology, Innovation

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round €1.20M 6
Icebreaker.vc Takoa Invest Athensmed
Icebreaker.vc, Takoa Invest +4
08 Apr 2022
Seed Round €550.00K 4
Icebreaker.vc Voima Ventures
Icebreaker.vc, Voima Ventures +2
29 Apr 2020

Finnadvance Alternatives & Competitors

View All Alternatives
Finnadvance vs
Emulate, Inc.
Emulate, Inc. United States

Our Organ-on-a-Chip technology provides a high-fidelity window into the inner workings of human biol...

Series F
71 employees
Biotechnology, Health Care
Compare Finnadvance vs Emulate, Inc.
Finnadvance vs
Dynacure
Dynacure France

Dynacure develops new treatments for orphan disorders, focusing on CNM through Dyn101 program with I...

Series C
Biotechnology, Health Care
Finnadvance vs
OrganoTherapeutics
OrganoTherapeutics Luxembourg

Using Midbrain Organoids for the development of new Therapeutics against Parkinson`s Disease.

9 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Finnadvance

Finnadvance creates small chips for drug discovery, mimicking organs and reducing animal testing, for rare diseases and personalized medicine.
Finnadvance was founded in 2018.
Finnadvance is headquartered in Finland.
Finnadvance operates in Biotechnology and Life Sciences. Its work centres on Drug discovery, Organ mimicking chips, Rare diseases and Personalized medicine.
Finnadvance has approximately 11-50 employees.
Finnadvance has completed 2 funding rounds, raising a total of $1.75M. The latest funding stage is Seed.
Top alternatives and competitors to Finnadvance include Emulate, Inc., Dynacure, OrganoTherapeutics, Everlume Bio, Pregenerate Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Finnadvance and Emulate, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Finnadvance, https://bouncewatch.com/company/finnadvance, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes